Olga Nigro

2.3k total citations · 1 hit paper
41 papers, 643 citations indexed

About

Olga Nigro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Olga Nigro has authored 41 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Olga Nigro's work include Cancer Immunotherapy and Biomarkers (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Olga Nigro is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Olga Nigro collaborates with scholars based in Italy, Spain and Germany. Olga Nigro's co-authors include Alice Indini, Michele Ghidini, Alberto Zaniboni, Mary Cabiddu, Antonio Bossi, Fausto Petrelli, Alessandro Iaculli, Gianluca Tomasello, Sandro Barni and Alessio Cortellini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Olga Nigro

33 papers receiving 636 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Obesity With Survival Outcomes in Patients With Cancer

2021 302 citations Olga Nigro et al. profile →

Peers

Olga Nigro

ONCOL

PRM

PHYSI

Alessandro Iaculli Italy

Tsukasa Ohnishi Japan

Marc Hilmi France

Bimin Shi China

Mahvish Muzaffar United States

Nivedita Arora United States

Luca Cantini Italy

Xiaoqing Xu China

Terry L. Ng Canada

Shih-Chen Chang United States

Alessandro Iaculli Italy

Olga Nigro

252 ×0.7

ONCOL

133 ×0.8

76 ×0.5

PRM

118 ×0.9

PHYSI

93 ×0.9

Citations per year, relative to Olga Nigro Olga Nigro (= 1×) peers Alessandro Iaculli

Countries citing papers authored by Olga Nigro

Since Specialization

Citations

This map shows the geographic impact of Olga Nigro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Nigro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Nigro more than expected).

Fields of papers citing papers by Olga Nigro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Nigro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Nigro. The network helps show where Olga Nigro may publish in the future.

Co-authorship network of co-authors of Olga Nigro

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Nigro. A scholar is included among the top collaborators of Olga Nigro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Nigro. Olga Nigro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergamaschi, Luca, Patrizia Gasparini, Manuela Marra, et al.. (2025). Distinct gut microbiota composition in pediatric patients with central nervous system (CNS) tumors: A comparative study. Neuro-Oncology Advances. 7(1). vdaf042–vdaf042. 2 indexed citations

Rizzo, Davide, Manuela Marra, Giorgio Gargari, et al.. (2025). QIIME2 enhances multi-amplicon sequencing data analysis: a standardized and validated open-source pipeline for comprehensive 16S rRNA gene profiling. Microbiology Spectrum. 13(9). e0167325–e0167325. 1 indexed citations

Morelli, Federica, Marta Lucchetta, Veronica Biassoni, et al.. (2025). Enhancing medulloblastoma classification with nanopore sequencing of FFPE samples. Neuro-Oncology Advances. 7(1). vdaf180–vdaf180.

Nigro, Olga, Veronica Biassoni, Elisabetta Schiavello, et al.. (2024). ATRT-06. PEDIATRIC INI1-NEGATIVE ATYPICAL TERATOID RHABDOID TUMORS TREATED WITH TAZEMETOSTAT AS MAINTENANCE THERAPY IN THE RELAPSE SETTING: AN ITALIAN SINGLE-CENTRE EXPERIENCE. Neuro-Oncology. 26(Supplement_4). 0–0.

Spreafico, Filippo, Olga Nigro, Giovanna Gattuso, et al.. (2023). Recommending exercise and sports for children and adolescents with a solitary kidney after a renal tumor: A view on current evidence-based risks and decisions. SHILAP Revista de lepidopterología. 1. 100003–100003.

Bergamaschi, Luca, Stefano Chiaravalli, Giovanna Sironi, et al.. (2022). Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables. Pediatric Blood & Cancer. 70(1). e30050–e30050. 4 indexed citations

Chiaravalli, Stefano, Luca Bergamaschi, Giovanna Sironi, et al.. (2022). Adult-type non-rhabdomyosarcoma soft tissue sarcomas in pediatric age: Salvage rates and prognostic factors after relapse. European Journal of Cancer. 169. 179–187. 7 indexed citations

Nigro, Olga, Giovanna Sironi, Andrea Ferrari, et al.. (2022). Managing Care during the COVID-19 Pandemic: The Point of View and Fears of Pediatric Cancer Patients’ Families. Children. 9(4). 554–554.

Ferrari, Andrea, Luca Bergamaschi, Stefano Chiaravalli, et al.. (2022). Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single‐center experience. Pediatric Blood & Cancer. 69(11). e29853–e29853. 15 indexed citations

10.

Schiavello, Elisabetta, Filippo Spreafico, Francesco Barretta, et al.. (2022). Ultra Short Course Chemotherapy for Early-Stage Non-Hodgkin’s Lymphoma in Children. Children. 9(9). 1279–1279.

11.

Nigro, Olga, Giovanna Sironi, Luca Bergamaschi, et al.. (2021). SARS‐CoV‐2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit. Pediatric Blood & Cancer. 68(10). e29240–e29240. 1 indexed citations

12.

Bergamaschi, Luca, Nadia Puma, Stefano Chiaravalli, et al.. (2021). Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center. Pediatric Blood & Cancer. 69(5). e29512–e29512. 8 indexed citations

13.

Podda, Marta, Elisabetta Schiavello, Carlo Alfredo Clerici, et al.. (2021). Children and adolescent solid tumours and high-intensity end-of-life care: what can be done to reduce acute care admissions?. BMJ Supportive & Palliative Care. 14(e3). e2642–e2648. 1 indexed citations

14.

Nigro, Olga, Claudio Chini, & Ilaria Proserpio. (2021). Molecularly targeted therapy for advanced gastrointestinal noncolorectal cancer treatment: how to choose? Past, present, future. Anti-Cancer Drugs. 32(6). 593–601. 5 indexed citations

15.

Nigro, Olga, et al.. (2021). Intestinal metastasis from breast cancer: Presentation, treatment and survival from a systematic literature review. World Journal of Clinical Oncology. 12(5). 382–392. 12 indexed citations

16.

Rossi, Giovanni, Alessandro Russo, Marco Tagliamento, et al.. (2020). Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient. Cancers. 12(5). 1125–1125. 48 indexed citations

17.

Rossi, Giovanni, Alessandro Russo, Marco Tagliamento, et al.. (2020). Präzisionsmedizin bei NSCLC im Zeitalter der Immuntherapie: Neue Biomarker zur Selektion der am besten geeigneten Therapie oder des am besten geeigneten Patienten. 8(6). 300–317. 1 indexed citations

18.

Nigro, Olga, et al.. (2020). Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor–positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?. Anti-Cancer Drugs. 31(5). 528–532. 3 indexed citations

19.

Chini, Claudio, Elena Magni, Ilaria Proserpio, et al.. (2020). Homcology: home chemotherapy delivery in a simultaneous care project for frail advanced cancer patients. Supportive Care in Cancer. 29(2). 917–923. 6 indexed citations

20.

Rossi, Giovanni, Aldo Pezzuto, Claudio Sini, et al.. (2019). Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario. Critical Reviews in Oncology/Hematology. 142. 26–34. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact